Northwestern: The number of childhood cancer survivors in the U.S. has increased, 
but the majority of those who have survived five or more years after 
diagnosis face chronic health problems related to their treatment, 
according to a new Northwestern Medicine study. The study is the first to estimate the prevalence of 
treatment-related chronic disease among survivors of childhood cancer at
 a national level. It found there are nearly 400,000 childhood cancer 
survivors in the U.S. as of 2011, up 60,000 from 2005. “We’ve been able to increase the number of survivors of pediatric 
cancer, but simply curing their disease isn’t enough,” said lead author 
Siobhan Phillips, assistant professor of preventive medicine at 
Northwestern University Feinberg School of Medicine. “We need a more 
coordinated approach to their care to help prevent or delay some of 
these chronic health problems that affect the quality of their lives. We
 want them to thrive, not simply survive.”
The study was published April 1 in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
“The magnitude of diseases at relatively young ages is quite 
striking, since you would not expect many of these diseases to be a 
problem in the general population until much older ages,” said Phillips,
 also a member of the Robert H. Lurie Comprehensive Cancer Center of 
Northwestern University.
Among the health problems experienced by childhood cancer survivors 
are mental impairment, anxiety, pain and physical limitations that 
affect daily living.
About 70 percent of the survivors of childhood cancers were estimated
 to have a mild or moderate chronic condition, and about 32 percent were
 estimated to have a severe, disabling, or life-threatening chronic 
condition. An estimated 35 percent of the survivors, ages 20 to 49, had 
neurocognitive dysfunction; about 13 to 17 percent of those in this age 
group had self-reported functional impairment, activity limitations, 
impaired mental health, pain or anxiety/fear.
“These facts should challenge all of us in the field not to be 
content simply with improving lifespan, but to dedicate the future of 
this field to improving the ‘health span’ of our survivors,” said Dr. 
Greg Armstrong, principal investigator of the Childhood Cancer Survivor 
Study and a pediatrician at St. Jude.
“Several important research questions arise from these findings as we
 consider how to increase our understanding of the chronic and late 
effects of treatment and how to best develop guidelines and 
interventions to treat these chronic morbidities in this important 
population,” said co-author Lynne Padgett, rehabilitation psychologist 
and program director of the NCI at the National Institutes of Health 
(NIH).
Childhood cancer survivors should have health care providers who are 
knowledgeable about their increased risk of chronic health problems, 
Phillips said. Northwestern’s Lurie Cancer Center has a comprehensive 
long-term follow-up program for adult survivors of pediatric cancer. The
 STAR Program follows survivors through adulthood, focusing on their special medical and psychological needs.
For the study, the researchers used cancer incidence and survival 
data recorded between 1975 and 2011 from nine U.S. Surveillance, 
Epidemiology, and End Results registries, and data from the Childhood 
Cancer Survivor Study cohort that had information on a range of 
potential adverse and late effects of cancer treatment from more than 
14,000 long-term survivors of childhood cancers at 26 cancer centers 
across the U. S. and Canada.
The Childhood Cancer Survivor Study is supported by grant U24-CA-55727 from the NCI of the NIH.